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The 5-HT1A receptor is a prototypical member of the large and diverse serotonin receptor family. One key role of this receptor is to stimulate cell
proliferation and differentiation via the extracellular signal regulated protein kinase (ERK) mitogen activated protein (MAP) kinase. There are few
reports on the ability of the 5-HT1A receptor to modulate other MAP kinases such as c-Jun N-terminal kinase (JNK), which is activated by various
extracellular stimuli, resulting in cell growth, differentiation, and programmed cell death. We report here for the first time that the 5-HT1A receptor
stimulates JNK. JNK stimulation was Pertussis toxin-sensitive and was mediated by Rho family low molecular weight GTPases. The 5-HT1A
receptor also increased apoptosis, which was mimicked by the MEK inhibitor PD98059, and blocked by the JNK inhibitor SP600125. These results
suggest that the 5-HT1A receptor stimulates both ERK-dependent anti-apoptotic pathways and JNK-dependent pro-apoptotic pathways in CHO
cells.
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Monoamines (serotonin, dopamine, norepinephrine, epi-
nephrine) serve as endogenous neurotransmitters. However,
monoamines have also been implicated in the pathologies of
several neurodegenerative and neuropsychiatric disorders due
to their ability to induce neuronal cell death. Dopamine, in
particular, has been shown to be pro-apoptotic in a number of
cell types, and consequently is a major contributor to the
pathophysiology of neurodegenerative diseases such as Parkin-Abbreviations: 5-HT, 5-hydroxytryptamine; CHO, Chinese hamster ovary;
ERK, extracellular signal-regulated protein kinase; GPCR, G protein-coupled
receptor; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein
kinase; MEK, mitogen-activated protein kinases kinase; MKK, mitogen-
activated protein kinase kinase; PBS, phosphate buffered saline; PKC, protein
kinase C; PLC, phospholipase C; PTX, Pertussis toxin; PVDF, polyvinylidene
fluoride
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doi:10.1016/j.bbamcr.2006.12.003son's disease [1–3]. Conflicting reports exist for serotonin, and
this particular monoamine can apparently be either apoptotic or
neuroprotective in neurons. This divergence is likely due to
differences in the expression of individual 5-HT receptor
subtypes in cells and/or tissues.
The 5-HT1A receptor is arguably the best characterized of the
5-HT receptor subtypes, having been studied for well over a
decade. It has been implicated in numerous physiological and
pathological processes including thermoregulation [4,5], sexual
behavior [6], memory [7], immune function [8], depression
[9,10], and anxiety [11,12]. The 5-HT1A receptor is a
prototypical G protein-coupled receptor (GPCR), which
couples to a broad array of second messengers including
adenylyl cyclase [13,14], phospholipase C [15], protein kinase
C [16], K+ channels [17–19], ERK mitogen-activated protein
kinase [20,21], and Na+/H+ exchange [20,22]. Virtually all of
these cellular effects are disrupted by pretreatment with Per-
tussis toxin (PTX), indicating that 5-HT1A receptors couple
specifically and/or preferentially to Gi/o-proteins.
The 5-HT1A receptor is generally believed to have anti-
apoptotic properties. In fact, some neuronal cell-types may
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cing conditions [23]. 5-HT1A receptor agonists have been
found to be effective in preventing toxin-induced apoptosis in
primary hippocampal and cortical cultures [24,25], and in
cultured neurons from chick embryo telencephalons [26].
These protective effects appear to derive from the ability of
the receptor to cause K+ channel-dependent membrane
hyperpolarization [27] and to activate ERK MAP kinases
[28,29].
Many GPCRs are capable of activating growth factor
receptor signaling cascades such as the mitogen-activated
protein kinases, ERK1 and ERK2. The 5-HT1A receptor is no
exception, and several groups have reported that the recombi-
nant 5-HT1A receptor can activate ERK MAP kinases in CHO
cells [20,21,30–33]. This activation is initiated by βγ-subunits
released from PTX-sensitive G-proteins, and involves the non-
receptor tyrosine kinase Src and Ca2+/calmodulin-dependent
receptor endocytosis [32]. In addition, Adayev et al. showed
that the 5-HT1A receptor utilizes ERK MAP kinases to inhibit
the proapoptotic enzyme caspase-3 in hippocampal HN2-5 cells
[28,29]. However, activation of mitogen-activated protein
kinases other than ERK by the 5-HT1A receptor has yet to be
investigated.
c-Jun N-terminal protein kinase (JNK) is a member of the
‘stress-activated’ MAP kinases. JNKs are potently activated by
stress signals such as UV- or X-irradiation, heat shock, and
osmotic shock, while typically being only modestly activated by
polypeptide growth factors and phorbol esters. JNK family
members are activated by dual phosphorylation on threonine
and tyrosine residues by the upstream kinases MKK4 and
MKK7, in some cases involving members of the Rho family of
small molecular weight GTPases [34]. Once activated, JNK
phosphorylates transcription factors such as c-Jun and ATF2.
The resulting alterations in gene expression contribute to the
mammalian stress response by affecting the cell cycle, DNA
repair and apoptotic pathways.
The roles of JNK MAP kinases have been extensively
studied, particularly in the central nervous system, where they
are thought to mediate neuronal differentiation and apoptosis. In
PC12 cells it was demonstrated that induction of the apoptotic
death response requires activation of JNK and p38MAP kinases,
in combination with simultaneous inhibition of ERK MAP
kinases [35]. Similar roles for JNK in the apoptotic response
have been outlined in sympathetic neurons [36] and SH-SY5Y
human neuroblastoma cells [37], as well as non-neuronal small
cell lung carcinoma cells [38], pancreatic β-cells [39], and
endothelial cells [40]. Thus, cellular survival and/or proliferation
following an extracellular stimulusmay ultimately depend on the
contributions of individual MAP kinase pathways.
In the current study, we report that the 5-HT1A receptor can
activate the c-Jun NH2-terminal kinase (JNK) in Chinese
hamster ovary (CHO) fibroblasts. This activation was rapid
(within 10 min) and sustained, and resulted in increased
programmed cell death marked by the formation of apoptotic
bodies and the observance of DNA fragmentation. This
suggests that the growth-promoting/neuroprotective and apop-
tosis-inducing effects of 5-HT1A receptor activation maydepend on the collective contributions of both the ERK and
JNK signal transduction pathways. The relative balance
between those pathways could mediate cell-specific responses
of the 5-HT1A receptor in and non-neuronal tissues.
2. Experimental procedures
2.1. Cell culture
CHO-K1 cells expressing ≈50 fmol of human 5-HT1A receptor/mg of
protein (CHO-5-HT1AR cells) were maintained in F12/HAMS medium,
supplemented with 10% fetal calf serum, streptomycin (100 μg/ml), penicillin
(100 units/ml), and gentamycin (400 μg/ml) at 37 °C in a 5% CO2-enriched,
humidified atmosphere. 24 to 48 h prior to each experiment, cells were switched
to serum-free medium containing 0.5% bovine serum albumin (Sigma).
2.2. Phospho-ERK immunoblots
Serum-starved CHO-5-HT1AR cells were treated with 8-OH-DPAT (10
−9 to
10−5 M) for varying time periods (0–60 min). Cells were then scraped into
Laemmli buffer and subjected to SDS-PAGE under reducing conditions.
Separated proteins were transferred to PVDF membranes and incubated with an
anti-phospho-ERK rabbit polyclonal antibody (Cell Signaling, Inc.; Beverly,
MA), followed by incubation with an horseradish peroxidase-conjugated goat
anti-rabbit secondary antibody (Cell Signaling). Immunoreactive bands were
visualized using a chemiluminescent method (CDP Star, New England BioLabs,
Beverly, MA) by exposing to Kodak X-AR film. To verify equal loading, the
same membranes were stripped using Re-Blot Plus (Chemicon International,
Inc.; Temecula, CA) and reprobed with an anti-total ERK antibody (Cell
Signaling). Each phospho-ERK value was normalized using the corresponding
total ERK value to control for the possibility of differential loading.
2.3. Jun kinase assay
Jun kinase activity was determined by precipitation with agarose beads
coupled to GST fusion proteins containing the JNK substrate, c-Jun, using a
commercial JNK activation kit (New England Biolabs). Briefly, serum-starved
cells were exposed to 8-OH-DPAT+/− other agents for the times indicated.
Cells were subsequently washed with ice-cold phosphate-buffered saline
(10 mM sodium phosphate, 150 mM NaCl, pH 7.4) and scraped in lysis
buffer. Lysates were then sonicated four times for 5 s each and centrifuged for
10 min at 14,000×g. Clarified extracts were incubated with 2 μg of c-Jun
fusion protein beads overnight at 4 °C and washed twice with lysis buffer and
twice with kinase buffer. The pellets were then resuspended in 50 μL of kinase
buffer in the presence of 100 μM ATP, and incubated for 30 min at 30 °C.
Reactions were terminated by adding 50 μL of 2× SDS loading buffer,
separated by SDS-PAGE, and transferred to PVDF. Membranes were
subsequently incubated with a rabbit polyclonal anti-phospho-c-Jun antibody,
followed by incubation with an horseradish peroxidase-conjugated goat anti-
rabbit secondary antibody. Phosphorylated c-Jun was then detected using
chemiluminescence by exposure to Kodak X-AR film. Each phospho-c-Jun
value was normalized using the corresponding total c-Jun value to control for
differential loading.
2.4. TUNEL staining
DNA cleavage and chromatin condensation associated with apoptosis were
detected using a modified fluorescent TUNEL assay (Apoptag® Plus
Fluorescein In Situ Apoptosis Detection Kit, Chemicon Intl.) according to
the manufacturer's instructions. Briefly, CHO-5-HT1AR cells were seeded on
glass coverslips and cultured to approximately 50% confluence. Cells were
then pretreated with 10 μM PD98059, 10 μM SP600125, or vehicle for
30 min, or PTX (200 ng/ml) overnight or toxin B (10 ng/ml for 2 h), and
cultured in serum-free medium in the continued presence of those agents for
48 h either in the presence or absence of 1 μM 8-OH-DPAT. Fixation was
performed in 1% paraformaldehyde/PBS, pH 7.4 for 10 min at room
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− 20 °C. Cells were then incubated with terminal deoxynucleotidyl transferase
(TdT) and digoxigenin-labeled nucleotides. Specimens were then incubated
with a flourescein-conjugated anti-digoxigenin antibody for 30 min at room
temperature and counterstained with 2 μM propidium iodide. Cover slips were
placed onto glass slides using mounting medium and viewed by fluorescence
microscopy. For each sample, the number of fluorescein-positive nuclei was
counted in ten high power fields.
2.5. Measurement of DNA fragmentation
Internucleosomal DNA fragmentation was assayed using an Apoptotic
DNA Ladder Detection Kit (Chemicon Intl.) according to the manufacturer's
instructions. Briefly, CHO-5-HT1AR cells grown to ∼50% confluence were
pretreated with 10 μM PD98059, 10 μM SP600125, or vehicle for 30 min,
and cultured in serum-free medium in the continuing presence of those agents
for 48 h either in the presence or absence of 1 μM 8-OH-DPAT. Cells were
then harvested, washed in PBS, and lysed. Crude lysates were incubated with
RNAse A and Proteinase K for 30 min at 37 °C and chromosomal DNA was
precipitated by incubation with ammonium acetate and ethanol overnight at
−20 °C. The resulting DNA pellets were washed with 70% ethanol and
loaded onto a 1% tris-acetate agarose gel containing 0.5 μg/ml ethidium
bromide. Stained DNA was visualized by transillumination with UV light and
photographed.
2.6. Statistical analysis
Results shown represent the means±S.E. of the number of experiments
indicated in every case. Statistical analysis was performed by two-tailed, paired
Student's t-test.3. Results
3.1. 8-OH-DPAT activates ERK in CHO fibroblasts expressing
the 5-HT1A receptor
CHO cells stably transfected with the 5-HT1A receptor
cDNA have been extensively utilized as a model to study the
signal transduction pathways mediated by this receptor. Using
this system, several groups, including ours, have documented
that the 5-HT1A receptor can activate ERK MAP kinases
[20,21,30–33]. We previously reported that the 5-HT1A receptor
activates ERK via the release of βγ-subunits from PTX-
sensitive G-proteins. Stimulation of ERK proceeds through the
Ras→Raf→MEK→ERK pathway, and appears to involve
reactive oxygen species generation and subsequent activation of
the non-receptor tyrosine kinase Src, as well as a receptor
endocytosis step that requires Ca2+/calmodulin [32]. As shown
in Fig. 1, stimulation with 8-OH-DPAT, a high-affinity agonist
selective for 5-HT1A receptors, produced concentration- and
time-dependent increases in ERK phosphorylation, which
reached a maximum at approximately 100 nM (Fig. 1A).
Phosphorylation was very rapid, reaching peak stimulation by
5 min (Fig. 1B), followed by a relatively rapid decrease, which
subsided by 60 min.
3.2. 8-OH-DPAT activates JNK in CHO fibroblasts expressing
the 5-HT1A receptor
Although the coupling of the 5-HT1A receptor to ERK has
been relatively well characterized, its involvement in theactivation of other MAP kinases has yet to be delineated. We
were particularly interested in whether the 5-HT1A receptor
could activate p38 and/or c-Jun N-terminal kinases, as these
MAP kinase family members have been closely associated
with cell differentiation, proliferation, and death. Efforts by
other groups to clarify this question have failed to
demonstrate 5-HT1A receptor-mediated activation of JNK or
other stress-activated MAP kinases. Interestingly, Chen et al.,
using rat brain tissue, reported that 8-OH-DPAT was unable to
modify phosphorylation of either the JNK or p38 MAP
kinases [41]. However, in that study 8-OH-DPAT also failed
to stimulate ERK MAP kinases, instead actually decreasing
basal levels of ERK phosphorylation in a concentration- and
time-dependent manner. In cultured human peripheral lym-
phocytes, Cloez-Tayarani et al. showed that the 5-HT1A
receptor activates ERK, but not p38 MAP kinases [42]. We
assayed the ability of the 5-HT1A receptor to activate JNK
using a kinase assay in which we measured the ability of
immunoprecipitated JNK to phosphorylate a GST fusion protein
of c-Jun. Stimulation of CHO-5-HT1AR cells with 8-OH-DPAT
resulted in concentration- and time-dependent increases in JNK
activity (Fig. 1C), with maximal activity at a concentration of
1 μM (Fig. 2A). JNK activity increased within 5 min and
reached a maximum at 20 min (Fig. 1D), with activity
decreasing slowly thereafter. 8-OH-DPAT induced an approxi-
mately 3- to 4-fold increase in JNK activity, compared to an
approximately 6- to 7-fold increase in ERK phosphorylation.
However, maximum JNK activation (20 min) occurred later
than for ERK activation (5 min), and was more sustained. We
considered the possibility that the 5-HT1A receptor might also
activate p38 MAPK in these cells, but were unable to detect
significant increases in p38 phosphorylation (not shown,
n=3).
3.3. 8-OH-DPAT-induced JNK activation is blocked by the
5-HT1A receptor antagonists WAY-100635 and S-UH-301 and
is mediated by PTX-sensitive Gi/o proteins
To verify that 8-OH-DPAT-induced JNK activation was me-
diated by the 5-HT1A receptor, we utilized the selective 5-HT1A
receptor antagonists WAY-100635 and S-UH-301. As shown
in Fig. 2A, pretreatment of cells with WAY-100635 (1 μM) or
S-UH-301 (10 μM) for 30 min prevented the activation of
JNK by 8-OH-DPAT. This result provides evidence that 8-OH-
DPAT-induced JNK activation is mediated by the 5-HT1A
receptor in CHO cells.
The 5-HT1A receptor previously has been shown to couple
specifically and preferentially to Gi/o proteins. We assessed the
role of Gi/o proteins in 5-HT1A receptor coupling to JNK
activation using PTX, which catalyzes the ADP ribosylation and
uncoupling of Gi/o proteins from receptors. We treated serum-
starved CHO cells with 200 ng/ml of PTX for 16 h, followed by
stimulation with 8-OH-DPAT for 20 min. As shown in Fig. 2B,
PTX pretreatment completely abrogated 8-OH-DPAT-induced
JNK activation. Thus, like other 5-HT1A receptor signal
transduction pathways, 8-OH-DPAT-induced JNK activation
appears to be dependent on PTX-sensitive Gi/o proteins.
Fig. 1. 8-OH-DPATstimulates ERK and JNKMAP kinases in CHO fibroblasts. (A) CHO cells stably expressing the 5-HT1A receptor were treated with 8-OH-DPAT (10
−9
to 10−5 M) for 20 min. Cell lysates were then resolved by SDS-PAGE, followed by immunoblotting with an anti-phospho-ERK antibody. Equal loading was verified by
reprobing the same blot with antibodies to total ERK. (B) CHO-5-HT1AR cells were treated with 1 μM8-OH-DPAT for the indicated times (0–60min). (C) After treatment
with 8-OH-DPAT (10−9 to 10−5 M) for 20 min, endogenous JNK was isolated from cell lysates by incubation with c-Jun fusion protein beads, and JNK activity was
measured using an in vitro kinase assay with c-Jun as the substrate. Proteins were then separated by SDS-PAGE, followed by immunoblotting with an anti-phospho-c-Jun
antibody. Equal amounts of JNK in cell lysates were verified using a JNK1/2 antibody. (D) CHO-5-HT1AR cells were treated with 1 μM 8-OH-DPAT for 0–60 min. Cell
lysates were analyzed for JNK activity as described above. Results shown for all four panels represent the mean±S.E. for at least three separate experiments.
Fig. 2. 8-OH-DPAT-induced JNK activation is sensitive to 5-HT1A receptor antagonists and is mediated by PTX-sensitive Gi/o proteins and Toxin B sensitive G proteins.
(A) CHO-5HT1AR cells were preincubated with the 5-HT1A receptor antagonists WAY-100635 (1 μM), S-UH-301 (10 μM), or vehicle for 30 min, and then stimulated
with 1 μM 8-OH-DPAT for 20 min. Cells were then lysed and JNK activity assays were performed as described. (B) CHO-5-HT1AR cells were pretreated with PTX
(200 ng/ml) overnight, then stimulated with 1 μM8-OH-DPAT for 20 min. Cells were then lysed and JNK activity assays were performed. (C) CHO-5HT1AR cells were
preincubated with toxin B (10 ng/ml) or vehicle for 2 h and then stimulated with 1 μM 8-OH-DPAT for 20 min. Cells were then lysed and JNK activity assays were
performed. For all three panels, equal amounts of JNK in cell lysates were verified using a JNK1/2 antibody. Results shown for all three panels represent the mean±S.E.
for at least three separate experiments.
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Rho family low-molecular-weight GTPases
Rho family GTPases have been implicated in the activation of
JNK by various stimuli. The 5-HT1A receptor can activate all
three major Rho family members (Rho, Rac, Cdc42) in CHO
cells (Turner and Raymond, manuscript in preparation). To
determine whether the 5-HT1A receptor utilizes Rho family
GTPases to activate JNK, we tested the effects of Clostridium
difficile toxin B, which glucosylates and inactivates Rho family
proteins without affecting Ras family members [43]. CHO cells
were incubated with 10 ng/ml of toxin B for 2 h, followed by
stimulation with 8-OH-DPAT for 20 min. As shown in Fig. 2C,
toxin B significantly decreased the activation of JNK. In contrast
toxin B had no effect on ERK phosphorylation (n=3, not
shown). These data suggest that JNK activation by the 5-HT1A
receptor is mediated, in part, by one or more members of the Rho
family of low-molecular-weight GTPases.
3.5. 8-OH-DPAT induces apoptotic chromatin condensation
and DNA fragmentation that are JNK-dependent
JNK and other stress kinases have been linked to apoptotic
cell death pathways in many cell types, including neurons.
Consequently, we wondered whether 5-HT1A receptor-mediated
activation of JNK could increase apoptosis in CHO cells.
Apoptotic cell death is typically preceded by the fragmentation
of genomic DNA. Cells undergoing apoptosis first produce
large (∼50–300 kb) DNA fragments via the endonucleolytic
degradation of higher-order chromatin structural organization.
This is closely followed by further endonucleolytic cleavage at
sites between nucleosomes, ultimately resulting in the forma-
tion of ∼180 bp nucleosomal DNA fragments [44]. In order to
test the possible involvement of the 5-HT1A receptor in
regulating apoptosis, CHO-5-HT1AR cells were pretreated
with the MEK inhibitor PD98059, the JNK inhibitor
SP600125, or vehicle, and then cultured in serum-free medium
for 48 h in the presence or absence of 1 μM 8-OH-DPAT,
following which we assessed DNA fragmentation using agarose
gel electrophoresis. The specificities of PD98059 and
SP600125 for blocking ERK and JNK, respectively, were
verified using phosphorylation state specific antibodies or
kinase assays (n=3 for both compounds, not shown). As shown
in Fig. 3A, 5-HT1A receptor activation by 8-OH-DPAT
increased DNA fragmentation both in vehicle-pretreated and
PD98059-pretreated cells. In contrast, agonist-induced DNA
fragmentation was inhibited almost completely in cells
pretreated with the JNK inhibitor SP600125. These results
suggest that the 5-HT1A receptor regulates apoptosis in CHO
cells. Using the same experimental treatment conditions, we
next assessed apoptosis using the TUNEL assay, which detects
DNA strand breaks by enzymatically labeling free 3′-OH
termini with digoxigenin-labeled nucleotides. Enzymatically
labeled 3′-OH termini were detected with a fluorescein-
conjugated anti-digoxigenin antibody, and cell nuclei were
counterstained with propidium iodide. As shown in Fig. 3B,
8-OH-DPAT-treated cells contained an increased number ofnuclei with condensed chromatin, as assayed by propidium
iodide staining. Likewise, these nuclei were also TUNEL-
positive, indicating that the cells were undergoing apoptosis.
These data are represented graphically in Fig. 3C. The
number of TUNEL(+) nuclei was increased in cells treated
with 8-OH-DPAT by approximately 2.5-fold. Interestingly,
cells pretreated with PD98059 and cultured either in the
presence or absence of 8-OH-DPAT, both had significantly
increased numbers of TUNEL(+) cells. This suggests that
ERK activation might antagonize both basal and 5-HT1A
receptor-induced apoptosis. In contrast, cells pretreated with
SP600125 and stimulated with 8-OH-DPAT showed no
increase in TUNEL(+) nuclei, suggesting that inhibition of
JNK can block 5-HT1A receptor-dependent apoptosis in these
cells. In aggregate, these results suggest that JNK activation is
involved in 5-HT1A receptor-mediated DNA fragmentation,
which is a hallmark of apoptosis.
In order to further verify the linkage between the 5-HT1A
receptor, JNK, and apoptosis, we incubated cells with toxin B
and PTX for 48 h, stimulated with 8-OH-DPAT or vehicle,
following which we measured TUNEL staining. We reasoned
that because toxin B and PTX block JNK activation, that those
toxins should also block 5-HT1A receptor-mediated apoptosis.
Indeed, Fig. 3D shows that PTX and toxin B each completely
blocks 8-OH-DPAT-induced increases in TUNEL staining
without affecting basal TUNEL staining. These results support
the existence of a pathway of activation of apoptosis in CHO
cells, which is shown in Fig. 4, and can be depicted in a linear
fashion as follows: 5-HT1A receptor→PTX-sensitive G
proteins→Rho family GTPase(s)→ JNK→apoptosis.
4. Discussion
In previous work, our laboratory showed that the 5-HT1A
receptor activates ERK MAP kinase in non-neuronal cells
through a pathway that involves PTX-sensitive Gi/o proteins and
the non-receptor tyrosine kinase c-src. We have reported in
the current work that the 5-HT1A receptor also activates c-Jun
N-terminal kinase, a MAP kinase family member often asso-
ciated with cell differentiation and apoptosis. JNK activation
was mediated by Gi/o proteins and one or more Rho family low-
molecular-weight GTPases. We also showed that the 5-HT1A
receptor induces apoptosis in CHO cells, as assayed by TUNEL
staining and DNA fragmentation. This apoptotic response was
mimicked by the MEK inhibitor PD98059, whereas it was
completely abrogated by the JNK inhibitor SP600125.
JNK is a member of the stress-activated family of MAP
kinases that is strongly activated by extracellular stimuli such as
UV light, hypotonicity, and chemical toxins, while typically
being only moderately activated by growth factors. These
kinases have diverse functions within the cell, including roles in
growth, differentiation, survival and death. The best-character-
ized function of JNK is its role in promoting apoptosis.
Persistent activation of JNK has been associated with apoptosis
in a variety of cell types, including HeLa cells [45], endothelial
cells [40], rat mesangial cells [46], PC12 neuronal-like cells
[35], and L929 fibrosarcoma cells [47]. Likewise, degenerating
Fig. 3. 8-OH-DPAT induces JNK-dependent DNA fragmentation. (A) CHO-5HT1AR cells were pretreated with 10 μM PD98059, 10 μM SP600125, or vehicle
for 30 min, and cultured in serum-free medium for 48 h either in the presence or absence of 1 μM 8-OH-DPAT in the continuing presence of inhibitors.
Cells were then lysed and treated with proteases and RNAses, followed by isolation of DNA cleavage products as described in Experimental procedures.
(B–C) CHO-5-HT1AR cells were seeded on glass coverslips and grown to approximately 50% confluence. Cells were then pretreated with 10 μM PD98059,
10 μM SP600125, or vehicle for 30 min, and cultured in serum-free medium for 48 h either in the presence or absence of 1 μM 8-OH-DPAT, in the
continuing presence of inhibitors. (B) Representative TUNEL staining fields for each condition. DNA cleavage and chromatin condensation were detected
using a modified fluorescent TUNEL assay (lower panels) and counterstained with propidium iodide (upper panels) as described in Experimental procedures.
Results shown are representative of three separate experiments. (C) For each sample analyzed via the TUNEL assay, the numbers of fluorescein-positive
nuclei were counted in ten high power fields. (D) Cells were pretreated with toxin B (10 ng/ml) for 2 h, PTX (200 ng/ml) overnight, or vehicle, and cultured
in serum-free medium for 48 h either in the presence or absence of 1 μM 8-OH-DPAT, in the continuing presence of inhibitors. TUNEL assays were then
performed, Results shown represent the mean±S.E. for at least three separate experiments.
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activity [48]. However, in some cases JNK activation has been
associated with cell survival. For example, JNK activation has
been shown to protect myocytes from nitric-oxide-induced
apoptosis and to protect HeLa cells from apoptosis after
photodynamic therapy [49]. Ultimately, the effect of JNK
activation on cell death and/or survival is likely sensitive to both
the time course of activation and accompanying molecular
signaling events within the cell.
Over the last few years, a small handful of GPCRs has been
found to activate JNK, often with different functional conse-
quences. For example, the calcium-sensing receptor was found
to stimulate JNK in MDCK cells [50], while melatonin mt1
and MT2 receptors have been shown to stimulate JNK via
PTX-sensitive and-insensitive G proteins in COS-7 cells [51].
Wylie et al. reported that muscarinic acetylcholine receptors
could activate JNK via a mechanism involving intracellular
Ca2+ in CHO cells [52]. We showed in this report that the
5-HT1A receptor can also activate JNK, in this case via
PTX-sensitive Gi/o proteins and Rho family low molecular
weight GTPases.Because JNK activation has been widely associated with
cell death and apoptosis, it is reasonable to assume that
GPCRs that can activate JNK may also contribute to the
apoptotic response. Although typically associated with
proliferative pathways, some GPCRs have been found to
play roles in apoptosis, including those for endothelin [53],
somatostatin [54,55], cannabinoids [56], angiotensin II [57],
and ATP [58]. In this report, we showed that the 5-HT1A
receptor induces apoptosis, as measured by chromosomal
condensation and DNA fragmentation. This effect was
mimicked by PD98059, an inhibitor of the ERK MAP kinase
pathway, while being completely inhibited in the presence of
the JNK inhibitor, SP600125. This suggests that the 5-HT1A
receptor may simultaneously activate both pro-apoptotic and
pro-survival pathways. A similar observation has been made
in cardiac myocytes, in which Zhu et al. showed that the β2
adrenergic receptor induces both a Gs-mediated pro-apoptotic
pathway, and a Gi-PI3K-Akt-mediated anti-apoptotic pathway,
although neither of these pathways was shown to involve
JNK [59]. Perhaps more analogous to the 5-HT1A receptor
signaling pathway is a report by Downer et al. showing that
Fig. 4. Schematic of JNK signaling by the 5-HT1A receptor. Proposed pathway
of 5-HT1A receptor-mediated activation of JNK and apoptosis in CHO cells. 8-
OH-DPAT induces the activation of ERK MAP kinase through a previously
described MEK-dependent pathway, and JNK MAP kinase through a pathway
involving Rho family low molecular weight GTPases, and terminating with the
activation of the c-Jun transcription factor. 5-HT1A receptor-mediated activation
of JNK induces apoptosis in CHO cells, which is typically opposed by the
protective effect of ERK activation.
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neurotoxicity via JNK in cultured cortical neurons [56]. In
this case, CB1 receptor stimulation resulted in the JNK-
dependent activation of caspase-3, an increase in the expression
of the pro-apoptotic mitochondrial-associated protein Bax, and
intranucleosomal DNA fragmentation. Interestingly, Adayev et
al. previously showed that the 5-HT1A receptor leads to a
decrease in anoxia-induced caspase-3 activity in hippocampal
HN2-5 cells via an ERK MAP kinase- and PKCα-dependent
pathway [28,29]. At first, this result may seem to be at odds with
the data presented in this report. However, 5-HT1A receptor-
induced ERK activation and inhibition of caspase-3 in HN2-5
cells are mediated by phospholipase C, whereas the 5-HT1A
receptor does not efficiently stimulate phospholipase C in CHO
cells. Thus, the ability of the 5-HT1A receptor to induce ERK-
mediated anti-apoptotic pathways or JNK-dependent pro-
apoptotic pathways may depend upon the relative contributions
of each pathway, as well as the cell-specific presence of
individual pathway components. In that regard, the finding that
the MEK inhibitor, PD98059, increases basal TUNEL staining
(Fig. 3C) supports the idea that MEK and/or ERK mediate(s)
anti-apoptotic effects in CHO cells. In order to confirm this
relationship, we treated cells with another MEK inhibitor,
U0126 (20 μM), which resulted in a statistically significant
doubling of TUNEL staining (n=3, not shown). Thus, the5-HT1A receptor can simultaneously activate a pro-apoptotic
pathway (JNK) and an anti-apoptotic pathway (MEK/ERK)
in CHO cells, the balance of which determines whether apop-
tosis is stimulated or not. This idea is not far-fetched, in that the
MEK/ERK pathway has previously been implicated in the
regulation of apoptosis [60]. The regulation of the MEK/ERK
and JNK pathways by the 5-HT1A receptor in CHO cells is
depicted schematically in Fig. 4.
The physiological relevance of the JNK pathway in 5-HT1A
receptor signaling is unclear. Most recent studies have suggested
that the 5-HT1A receptor is anti-apoptotic and neuroprotective.
However, the anti-apoptotic effects of the 5-HT1A receptor
derive from multiple signal transduction pathways, depending
on cell type and the concurrent cellular insult. For example,
5-HT1A receptor-mediated protection against cyanide-induced
cytotoxic hypoxia and glutamate-induced excitotoxicity in
primary neuronal cell cultures from chick embryo cerebral
hemispheres appears to be mediated by opening of K+ channels
and consequent attenuation of the depolarization required for
opening of NMDA and voltage-dependent Ca2+ channels [27].
As previously mentioned, anoxia-induced apoptosis of HN2-5
hippocampal cells is attenuated by 5-HT1A receptor stimulated
and ERK-dependent caspase-3 inhibition [28,29], whereas in
astrocytes the 5-HT1A receptor can apparently block apoptosis
by increasing the release of the neurite extension factor S-100β
[61]. However, as reported here, it is likely that the 5-HT1A
receptor stimulates a multitude of anti-apoptotic and pro-
apoptotic pathways. The ultimate effects of the 5-HT1A receptor
depend on numerous factors including the duration of stimula-
tion, predominance of individual pathways, and the overall
cellular environment.
In conclusion, we have reported for the first time in this work
that the 5-HT1A receptor stimulates JNK MAP kinase in CHO
cells. JNK stimulation was PTX-sensitive and mediated by Rho
family lowmolecular weight GTPases. Furthermore, the 5-HT1A
receptor increased apoptosis, as detected by DNA laddering and
TUNEL staining of CHO cell monolayers. 5-HT1A receptor-
induced apoptosis was accentuated by MEK/ERK inhibition,
whereas it was completely blocked by maneuvers that neutralize
PTX-sensitive G proteins, Rho family GTPases, and JNK. In
aggregate, these results suggest that the 5-HT1A receptor can
simultaneously stimulate both ERK-dependent anti-apoptotic
pathways and JNK-dependent pro-apoptotic pathways, and that
the ultimate effect of 5-HT1A receptor stimulation is probably
dependent on the respective contributions of these and other
pathways.
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